4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-25-000089
CEO sold 15,192 shares at $1.72 ($26,196)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-03 | Sale : show line 1 in the form 10b5-1 | −15,192 | $1.72 | $26,196 | 280,282 | D |
| Open-market sales · 15,192 sh · avg $1.72 · $26,196 | ||||||
Loading xslF345X05/wk-form4_1749076593.xml…